Recombinant CD37 (Naratuximab Biosimilar) 抗体
This Humanized Chimeric antibody specifically detects CD37 (Naratuximab Biosimilar) in ELISA 和 WB. It exhibits reactivity toward 人.
产品编号 ABIN7538072
发货至:
中国
Contact our Customer Service for availability and price in your country.
Contact Info
Our Local Distributor
中国
北京 101111
北京 101111
No. 88 KeChuang 6th Street
Beijing Economic Technological Development Area
Room 801-803
Quick Overview for Recombinant CD37 (Naratuximab Biosimilar) 抗体 (ABIN7538072)
抗原
CD37 (Naratuximab Biosimilar)
抗体类型
Recombinant Antibody
适用
人
宿主
Humanized
克隆类型
Chimeric
标记
This CD37 (Naratuximab Biosimilar) antibody is un-conjugated
应用范围
ELISA, Western Blotting (WB)
质量等级
Research Grade
-
-
Expression System
- Mammalian cells
-
原理
- Naratuximab Biosimilar – Anti-CD37 mAb - Research Grade
-
产品特性
- Antibody Type: IgG1-kappa
-
纯化方法
- Recombinant antibody expressed in mammalien cells and purified.
-
纯度
- > 85%
-
亚型
- IgG1 kappa
-
-
-
-
限制
- 仅限研究用
-
-
-
缓冲液
- PBS buffer PH7.5
-
储存条件
- -80 °C
-
储存方法
- store at -80°C
-
-
- CD37 (Naratuximab Biosimilar)
-
背景
- Naratuximab is a humanized monoclonal antibody that binds CD37. Naratuximab can be used to synthesize an ADC compound, Naratuximab emtansine.
-
CAS-编号
- 1622327-39-2
抗原
-
You are here:
